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Introduction
Hair follicles consist of an external epithelial envelope (outer root
sheath; ORS) that is continuous with the epidermis, ensheaths the
shaft and its thin internal envelope (inner root sheath, IRS) and
embedded in it is a distinct group of specialized dermal cells, the
papilla (DP). This core is itself surrounded by mesenchymal tissue,
the dermal sheath (DS) (Paus and Cotsarelis, 1999). The hair follicle
demonstrates a remarkable ability for self-regeneration, undergoing
a regular succession of growth (anagen) and regression (catagen)
phases associated with replacement of the old hair shaft by a new
one (Hardy, 1992). This cyclic event requires particular interactions
between the epithelial and the mesenchymal components of the
follicle (Jahoda and Reynolds, 1996). The downgrowth of the
follicle as well as the survival of cells in the epithelial sheaths are
under the active control of signaling molecules produced by the
papilla (Cohen, 1961; Jahoda et al., 1984; Reynolds et al., 1991).
Cyclic shut down of this activity leads to disorganization, massive
apoptosis and partial follicular regression initiated in the lower part
of the follicle (Botchkarev and Kishimato, 2003). Thus, entry into
new anagen requires the reactivation of DP activity, leading to
stimulation of epithelial stem cells present in the permanent portion
of the ORS to build a new functional follicle (Cotsarelis et al., 1990).
DP and DS cells are thought to derive from the same embryonic
founder cells (Oliver, 1966). They are generated from mesenchymal
cells in the embryonic dermis in response to signals generated by
the epidermis (Hardy, 1992; Oro and Scott, 1998). DP cells are
secretory cells that work together as an organizer, regulating growth
and renewal of neighboring tissues. External DS cells provide
structural reinforcement to the follicle. They express smooth muscle
actin (Jahoda et al., 1991) and, thus, are able to generate strong
contractile forces. Furthermore, DS cells located closest to the
papilla, i.e. in the dermal sheath cup (DSC), exhibit an intermediate
phenotype with both DP and DS characteristics (McElwee et al.,
2003). They express smooth muscle actin and also a low level of
alkaline phosphatase, considered to be a DP marker. Moreover, they
can substitute for the DP in inducing the formation of new hair
follicles when transplanted (McElwee et al., 2003).
The two dermal compartments are physically connected (Oliver,
1991; Jahoda, 1998) and a two-way traffic of cells between the DS
and DP has been postulated to explain cyclic variation in DP size
in the absence of detectable cell death and division (Elliott et al.,
1999; Tobin et al., 2003). Indeed, in adult mice, DP cells are
quiescent, whereas DS cells undergo sporadic proliferation (Pierard
and de la Brassinne, 1975; Jahoda, 1998). Experimental evidence
suggests that the DS is a cell reservoir for slow renewal of the papilla
(Tobin et al., 2003). In addition, the capacity of grafted DSC cells
to induce follicle formation probably relies on their ability to give
rise to DP cells (McElwee et al., 2003). Conversely, DP cells
participate in DS reconstitution in transplantation experiments,
where some grafted cells are incorporated into newly formed DS
(Jahoda, 1992; McElwee et al., 2003).
Overall, this points to a significant level of cell plasticity and
suggests that change in the differentiation status of DP and DS cells
might play a physiological role during the hair cycle. However, it
is unclear whether variation in tissue size, cell renewal and cross-
reconstitution of DP and DS rely on the presence of common
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undifferentiated precursors (Lako et al., 2002; Jahoda et al., 2003;
Fernandes et al., 2004) and/or on the transdifferentiation of mature
mesenchymal cells. Despite the fundamental and the practical
interest in understanding how two very specialized cell types can
regenerate cells of the alternate phenotype, nothing is known about
the molecular mechanisms or factors involved.
In situ hybridization experiments suggest that extracellular
proteolytic activity is involved in the hair cycle. First, the protease-
activated thrombin receptor 1 [coagulation factor II (thrombin)
receptor, F2R; hereafter referred to as PAR-1] is expressed during
the entire cycle in the DS, including a bridge of DSC cells
invaginating into the DP area at the bottom of the follicle, but is
present only during catagen in DP cells (Anan et al., 2003). Second,
protease nexin-1 [also known as serpin peptidase inhibitor
(SERPINE2), hereafter referred to as PN-1], a serine protease
inhibitor targeting thrombin, plasminogen activators tPA and uPA,
trypsin or plasmin (Baker at al., 1980; Guenther et al., 1985; Stone
et al., 1987), is prominently expressed in hair follicle dermal cells
during anagen, but is downregulated during catagen (Yu et al., 1995).
Thus, the absence of PAR-1 and the presence of PN-1 in the DP
during anagen appear to be a ‘double-lock’ which prevents
thrombin-signaling activity on these cells. By contrast, the absence
of inhibition by PN-1 and the upregulation of PAR-1 during
catagen may allow efficient thrombin signaling through activation
of its receptor. This suggests that the tight control of thrombin
activity plays a role in the proper functioning of the DP. Thrombin
can trigger fibroblast proliferation (Chambard et al., 1987) but can
also promote their differentiation into myofibroblasts (Bogatkevich
et al., 2001). These observations prompted us to investigate the role
of PN-1-mediated thrombin inhibition on the renewal and
differentiation of hair follicle dermal cells during the hair cycle.
In this study, we have established that control of thrombin
signaling is a key component of hair follicle dermal cell plasticity.
Using cultures of cells derived from PN-1–/– mice, we show that
the inhibition of thrombin signaling antagonizes the acquisition of
a DS-like phenotype by DP cells by preventing activation of the
phosphoinositide 3-kinase (PI3K)-Akt pathway. Furthermore, we
observe that PI3K pathway activation and expression of the
myofibroblastic marker α smooth-muscle actin (SMA) are also
altered in vivo by a change in the thrombin-PN-1 balance in both
PN-1–/– mice and physiologically during anagen/catagen transition
in wild-type animals.
Results
PN-1 colocalizes with thrombin and controls its activity in
vibrissal follicles
To precisely monitor PN-1 expression during embryonic
development and the cycle of hair/whisker follicles, a PN-1 reporter
mouse showing bicistronic expression of -galactosidase from the
PN-1 locus (Kvajo et al., 2004) was examined using X-Gal staining
and immunohistochemistry with an anti PN-1 antibody. PN-1 was
first expressed at E16.5 in aggregated cells below the hair germ in
a position corresponding to the presumptive DP (Fig. 1A).
Expression then extended to the maturing DS as hair morphogenesis
proceeded (Fig. 1B ‘anagen’ and 1C). In agreement with in situ
hybridization data published by Yu et al. (Yu et al., 1995), secreted
PN-1 was detected in and around its area of synthesis until catagen
of the follicular cycle, was absent during catagen (Fig. 1B) but its
synthesis resumed in DP and DS during renewed anagen (Fig. 1C).
In cycling follicles, PN-1 was also transiently expressed at the end
of catagen in the ORS until the early phases of the new anagen
(Fig. 1C). The tip of the growing hair progressed through these PN-
1-expressing cells, which then surrounded both the growth cone of
the new shaft and the club of the previous one (Fig. 1C).
Thrombin, the main PN-1 target, was also detected in whisker
follicles by immunohistochemistry (Fig. 1D). It tightly colocalized
with PN-1 both in DS and in a subset of ORS cells with the same
spatiotemporal pattern (Fig. 1, compare D and C). Such
colocalization allowed control of thrombin, illustrated by a twofold
increase in thrombin-specific proteolytic activity measured in
homogenates from PN-1–/– microdissected whisker follicles (Fig.
1E). This increased activity reflected the global absence of inhibition
in all follicular tissues but appeared to be due more specifically to
de novo accumulation of thrombin in the DP of PN-1–/– mice (Fig.
1F). This overload probably reflects a failure in the clearance of
the protease by the low density lipoprotein receptor-related protein-
1 (LRP-1), which controls internalization of PN-1-thrombin
complexes (Knauer et al., 1997).
PN-1 limits thrombin-induced proliferation and acquisition of a
myofibroblastic phenotype in cultured DP cells
Immunocytochemical analysis indicated that DP cells from wild-
type anagen follicles homogeneously expressed PN-1 and LRP-1
in culture (Fig. 2A,B). NCAM and the DP-specific marker alkaline
phosphatase [AP (Handjiski et al., 1994)] confirmed the identity
and homogeneity of our cultures (Fig. 2D,E). BrdU incorporation
indicated that the in vivo quiescent DP cells recovered the ability
to divide when they were taken out of their niche and cultured as
adherent cells in a proliferation-permissive medium containing FCS
and EGF (Fig. 2F). Furthermore, as already observed (Jahoda et
al., 1991; Reynolds et al., 1993), cultured DP cells also
homogeneously expressed alpha smooth muscle actin (SMA; Fig.
2F), which is only produced in vivo in the dermal sheath
compartment (Jahoda et al., 1991). Cultured DP cells thus had the
combined characteristics of the DP and DS cell types. They
nevertheless exhibited both lower proliferation rate and lower
expression of SMA contractile protein than cultured DS cells
(supplementary material Fig. S1A,B).
Except for PN-1 expression, the same markers were detected in
DP cells from PN-1–/– follicles. However, these PN-1–/– DP cells
exhibited a significantly higher proliferation capacity than those
derived from wild-type littermates. The difference was quantified
by counting cells at different time points after cell plating. The
population doubling time of about 23 hours for wild-type cells was
shortened to 15 hours for PN-1-deficient DP cells (Fig. 3A). In the
FCS-supplemented medium used to culture those cells, about 0.05
U/ml of thrombin proteolytic activity was detected (data not
shown). Inhibition of this activity by 100 M hirudin for 12 hours
triggered a significant decrease in DP cell proliferation, measured
by BrdU incorporation, for cells of both genotypes. This effect was
more pronounced for PN-1–/– cells, and hirudin treatment abolished
the difference between the wild-type and mutant cells (Fig. 3B).
Therefore, the proliferation of cultured DP cells was largely due to
the presence of active thrombin in the culture medium and the lack
of thrombin inhibition was responsible for the observed faster
proliferation of PN-1-deficient cells.
Cells double in size before entering mitosis and mass increase
is generally coordinated with, and somehow controls, cell division.
However, the variation in size of quiescent DP cells in vivo suggests
that these cells might uncouple size increase and cell division (Tobin
et al., 2003). Consequently, we examined whether variations in
proliferation rate were linked and proportional to changes in cell
Journal of Cell Science 121 (9)
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mass. Cells were arrested in S phase using the DNA polymerase
inhibitor aphidicolin and the increase in their volume, known to be
proportional to the amount of newly synthesized material (Conlon
et al., 2001), was measured. When tested in medium containing 1%
serum over a 24-hour period, the absence of PN-1 caused a 2.5-
fold increase in cell volume (Fig. 3C). It thus did not dissociate the
two processes. Overgrowth of PN-1–/– cells was demonstrated to
be directly due to lack of the protein, because it was abolished by
addition of recombinant PN-1 (Fig. 3C). However, PN-1
internalization or signaling through LRP (Knauer et al., 1997) was
not required. Blockade of PN-1 binding to the LRP receptor by the
antagonistic receptor-associated protein RAP, used at a concentration
interfering with proliferation (Vaillant et al., 2007), did not affect
cell volume increase (Fig. 3C).
SMA protein level was higher in the absence of PN-1 both in
lysates of cultured DP cells and in extracts from hairy skin (Fig.
4A). This correlated with a change in contractile properties of
cultured cells. Wild-type DP cells embedded in a 3D collagen gel
matrix, promoted a mild 10-15% contraction of the gel over 48
hours. By contrast, PN-1–/– cells caused an efficient 30-40%
contraction of the collagen matrix (Fig. 4B). Thrombin activity was
found to be responsible for stimulated contractile properties of DP
cells. Indeed, a daily hirudin treatment over 2 days decreased the
efficiency of gel contraction and, moreover, abolished the difference
between PN-1–/– and wild-type DP cells (Fig. 4C). The involvement
of thrombin in the stimulation of cell proliferation and gel
contraction was quite surprising since its receptor, PAR-1, was not
detected in vivo in the DP cells of anagen follicles from which our
cultures were derived (Anan et al., 2003). PAR-1 was, however,
homogeneously expressed in our DP cultures (Fig. 2C). The
involvement of PAR-1 in the thrombin effect was substantiated
because its activation by the thrombin receptor-activating peptide
(TRAP) efficiently substituted for serum in the collagen gel
contraction assay. A control peptide with the retro-sequence had no
effect (Fig. 4D).
Thrombin stimulates both growth and contractibility through
activation of the PI3K-Akt pathway
It is well documented that the PI3K pathway regulates cell
proliferation by controlling protein synthesis and G1-S transition
in different cell types (Collado et al., 2000; Medema et al., 2000).
In addition, mTOR (also known as FRAP1) responds to growth
factors independently or dependently of the PI3K pathway
(Wullschleger et al., 2006). Consequently, specific inhibitors of
PI3K and mTOR (LY294002 and RAD001, respectively) were
added for 24 hours to test the involvement of these pathways in
regulating cell cycle progression and change in cell volume.
LY294002 had a strong effect on proliferation and volume increase
of DP cells in culture (Fig. 5A,B). Furthermore, only LY294002
Fig. 1. PN-1 colocalizes with thrombin and controls its activity in vibrissal
follicles. (A) X-Gal (blue) staining of cryostat sections from embryonic hair
(E18.5) and whisker (E16.5) follicles of PN-1 knockin (KI) mice during early
follicle morphogenesis. (B) Immunohistochemistry (brown staining) of
follicles during anagen (P23) and catagen (P25) with an antibody against PN-1
(note that black areas are melanin, not staining). (C) X-gal staining of adjacent
longitudinal cryostat sections of dissected postnatal follicles from a PN-1 KI
mouse at early anagen (P27). (D) Thrombin immunostaining of a longitudinal
cryostat section of a full-length early anagen follicle from a wild-type mouse
showing the similarity to PN-1 localization (cf. C) in DS and a subset of ORS
cells. (E) Comparison of thrombin proteolytic activity with or without addition
of recombinant PN-1 (rPN-1; 1 g/ml) to anagen whisker follicle
homogenates from wild-type and PN-1–/– mice. ***Significant difference
(P<0.001). (F) Higher magnification of thrombin immunostained follicular
bulbs from wild-type and PN-1–/– mice showing thrombin accumulation in the
DP in the absence of PN-1. pDP, presumptive dermal papilla; pDS,
presumptive dermal sheath; DP, dermal papilla; DS, dermal sheath; ORS, outer
root sheath; C, capsula.
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specifically abolished the difference between PN-1–/– and wild-type
cells. RAD001 effectively inhibited volume increase and
proliferation of DP cells but its effect was weaker and it did not
eliminate the difference between the two cell types (Fig. 5A). Those
effects were not biased by cytotoxicity, since no fragmented nuclei
were observed. Moreover, aphidicolin, LY294002 and RAD001
showed no effect on cell viability, visualized by Trypan Blue
staining. In each case, around 95% of the cells of each genotype
were healthy at the end of the experiments when performed in 10%
FCS supplemented medium (data not shown).
PI3K, as well as protein kinase C (PKC), also influenced the
contractile properties of DP cells (Fig. 5C). Treatments with
LY294002 or with a specific inhibitor of PKC (GF103203X)
strongly limited collagen gel retraction. Nevertheless, only PI3K
was required for thrombin-mediated stimulation of contraction.
Indeed, after a pretreatment with hirudin, which abolished the
difference between wild-type and PN-1–/– cells (Fig. 4C), addition
of thrombin restimulated DP cell-mediated gel contraction, restoring
the difference between the two cell types (Fig. 5C). This
restimulation was prevented by LY294002 but insensitive to
GF103203X (Fig. 5C). Thrombin stimulated contraction even in
the presence of aphidicolin, indicating that its effect was not due
to a differential increase in the number of wild-type and PN-1–/–
cells (Fig. 5C).
Akt, as a downstream target of PI3K, was overactivated in the
absence of PN-1. Whereas the total amount of Akt protein was
similar in wild-type and PN-1–/– DP cells, the relative amount of
phosphorylated protein was higher in PN-1–/– cells (Fig. 5D). This
enhanced phosphorylation disappeared after a 24-hour treatment
with LY294002, indicating that it was due to an increase in PI3K
activity (Fig. 5D). As expected, addition of thrombin to wild-type
DP cells led to a strong and rapid increase in Akt phosphorylation,
which was also prevented by addition of LY294002 (Fig. 5E). PAR-
1 was found to mediate the thrombin effect on the PI3K pathway.
Indeed, TRAP but not the control peptide triggered Akt
phosphorylation as efficiently as thrombin (Fig. 5F). Finally, the
high level of Akt phosphorylation, as a result of the reduced
inhibition of the serum-derived thrombin, was close to its maximum
in PN-1–/– cells. Consequently, compared to wild-type cells, one-
tenth the amount of purified thrombin was sufficient for Akt
phosphorylation to reach a plateau in PN-1–/– cells (Fig. 5G).
The physiological relevance of PI3K pathway dysregulation was
confirmed by comparing Akt phosphorylation in anagen whisker
follicles from PN-1–/– and wild-type mice (Fig. 5H). By contrast to
Akt, PTEN phosphorylation was not affected, indicating that this
most important intracellular modulator of the PI3K pathway was
not involved (Fig. 5H). The specificity of a PI3K pathway
stimulation was further demonstrated by the observation that the
Erk pathway was not affected by the absence of PN-1 (Fig. 5H).
Finally, the PI3K signaling pathway was globally more active in
anagen follicles of PN-1–/– mice, presumably as a consequence of
Akt activation, because several downstream members of the PI3K
signaling cascade, S6 kinase, GSK3 (glycogen synthase kinase 3)
and members of the Forkhead box transcription factor FOXO family
(FKHR and AFX), were also more phosphorylated (Fig. 5H).
Thrombin effect on cultured DP cells mimics changes
occurring in vivo during catagen
Signaling from the DP during anagen stimulates growth and
survival of neighboring keratinocytes (Botchkarev and Paus, 2003).
We controlled that its function was maintained in vitro. We found
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Fig. 2. Cultured DP cells exhibit characteristics of both DP and DS cells.
Immunostaining of cultured wild-type DP cells from microdissected dermal
papilla. (A) PN-1, (B) LDL receptor-related protein-1 (LRP-1), (C) thrombin
receptor PAR-1, (D) NCAM, (E) alkaline phosphatase (AP), (F) smooth
muscle actin (SMA) and BrdU (10 M, 2 hours).
Fig. 3. PN-1-mediated inhibition of thrombin activity affects proliferation of cultured hair follicle dermal cells. (A) Growth of wild-type and PN-1–/– DP cell in
medium containing 10% FCS. Cells were plated at 200 cells/mm2 and average cell density from three dishes was calculated at different time points after plating.
(B) Effect of hirudin-mediated inhibition of thrombin in serum-supplemented culture medium on cell proliferation. Hirudin (100 M) was added 24 hours before a
pulse of BrdU (10 M, 2 hours). ***Significant difference from wild-type cells (P<0.001). (C) Effect of PN-1 on volume increase. Cells transferred to medium
containing 1% FCS were blocked in S phase by aphidicolin (1 g/ml) for 24 hours and then cultured for an additional 24 hours with or without recombinant PN-1
(rPN-1; 15 nM) in the absence or presence of RAP (1 g/ml). Change in mean volume was calculated for non-dividing cells in three dishes for each treatment.
**Significant difference between PN-1–/– and wild-type cells (P<0.01); *significant difference between PN-1–/– cells with or without rPN-1 (P<0.05).
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that DP cells used as a feeder layer were indeed more efficient than
DS cells in supporting keratinocytes growth (supplementary material
Fig. S1C). We, therefore, compared the abilities of wild-type and
PN-1–/– DP cells to sustain keratinocyte proliferation and survival
in culture. The growth of human YF29 keratinocytes plated on
confluent layers of inactivated DP cells was monitored (Fig. 6A)
and quantified (Fig. 6B) after 8 days in culture. Keratinocytes plated
on PN-1–/– DP cells formed threefold fewer clusters, which were
much smaller than those formed on wild-type cells. PN-1-deficient
DP cells supported the growth of 8- to 50-cell clusters, few having
more than 30 cells. By contrast, on wild-type DP feeder layers, about
30% of the clusters contained 50-200 cells. The number of such
large clusters was almost equal to the total number of clusters
obtained on the PN-1–/– feeder layer.
As the keratinocyte culture medium also contained FCS, the
results could reflect a protective effect of PN-1 against thrombin
acting directly on keratinocytes, or a prior thrombin-dependent shift
in DP cells properties. Therefore, we tested the effect of signaling
molecules secreted by DP cells on keratinocytes plated on collagen
and cultured in serum-free medium. As minimal medium
conditioned by wild-type and PN-1–/– DP cells did not allow long
term proliferation and survival of those cells, we evaluated the short
term stimulation of the Akt pathway, known to sustain keratinocytes
survival (Calautti et al., 2005), by monitoring the level of
phosphorylated Akt by immunoblot analysis. As shown in Fig. 6C,
medium conditioned by wild-type DP cells stimulated Akt
phosphorylation in keratinocytes. This was abolished by
pretreatment of DP cells with thrombin. Correspondingly, medium
conditioned by PN-1–/– DP cells did not stimulate Akt
phosphorylation (Fig. 6C). Thus, the reduced survival of
keratinocytes on PN-1–/– DP feeder cells was most likely to be due
to a direct effect of thrombin on DP cells leading to the loss of their
growth-supporting activity.
In vivo, a shift in DP activity allows cell death and regression
of the follicle during catagen (Botchkarev and Kishimato, 2003).
Since PAR-1 upregulation and disappearance of PN-1 both occur
in DP cells during catagen, we investigated whether the
transformation seen in cultured PN-1–/– DP cells mimics the process
taking place in vivo during catagen. As suspected, an increase in
SMA was detected in protein extracts from catagen wild-type
whisker follicles (Fig. 7A). Moreover, SMA protein was present
only in the DS during anagen (Fig. 7B) but was strongly expressed
in DP cells and in embedding trailer connective tissue during catagen
(Fig. 7B,C). Thus, DP cells switched to myofibroblastic cells during
catagen. Furthermore, catagen DP cells still expressed alkaline
phosphatase (Fig. 7C). They thus exhibited markers of both DP and
DS cells as observed for cultured DP cells (Fig. 2).
Discussion
Our results provide evidence that thrombin stimulation of the PI3K-
Akt pathway allows DP cells to express a DS-like phenotype.
Because of the presence of thrombin, cultured whiskers DP cells
accelerate proliferation, acquire new contractile properties, and
simultaneously reduce their growth-supporting activity on
keratinocytes. These effects require proteolytic activation of the
thrombin receptor PAR-1 and are negatively controlled by the serine
protease inhibitor PN-1. In vivo, myofibroblastic contractile
properties are restricted to PAR-1-expressing DS cells during
anagen and are enhanced in PN-1–/– follicles. Myofibroblastic
characteristics are also acquired by wild-type pelage DP cells that
drop their supporting activity on surrounding epithelial cells during
catagen because they re-express PAR-1 and downregulate PN-1.
Thus, our data strongly suggest that a tight control of thrombin
proteolytic activity is one of the mechanisms of DP-DS cell
plasticity.
Expression of thrombin coincides with that of PN-1. Furthermore,
higher thrombin activity is detected in whiskers from mice lacking
PN-1. These in vivo observations justified the use of PN-1–/– mice
and of their DP cells to investigate the physiological effect of
thrombin signaling. In vitro, determination of cell population
doubling time, rate of BrdU incorporation and volume increase
before mitosis provide evidence for the impact of PN-1 sensitive
thrombin activity on DP cell proliferation. Of special interest is the
observation that all BrdU-positive cells express the myofibroblastic
marker SMA, indicating modifications in their contractile properties.
This is confirmed by the enhanced contractile capabilities of the
faster proliferating DP cells derived from PN-1–/– mice. Our results
clearly indicate that the cellular events triggered by thrombin in
highly specialized DP cells solely require activation of the PI3K-
Akt pathway. Thrombin has also a dual effect on fibroblasts, namely
stimulating both their proliferation (Chambard et al., 1987) and their
differentiation into myofibroblasts (Bogatkevich et al., 2001).
However, as these events are mutually exclusive (Grotendorst et
al., 2004), the two effects of thrombin may be antagonistic. In these
cells, stimulation of proliferation is mediated by the PI3K-Akt
Fig. 4. PN-1 protects DP cells from thrombin-stimulated expression of a
myofibroblastic phenotype. (A) Level of SMA protein in cultured wild-type
and PN-1–/– DP cell lysates (upper panel) and in extracts from the hairy skin of
wild-type and PN-1–/– mice (unplucked; unP) and excised 3 days after
stimulation of SMA expression by hair plucking (P) (lower panel).
(B) Collagen gel contraction by embedded wild-type and PN-1–/– DP cells
after 48 hours in medium containing 10% FCS. ***Significant difference
from wild-type cells (P<0.001). (C) Effect of thrombin inhibition by hirudin
(100 M) on gel contraction by DP cells. (D) Effect of PAR-1-activating
peptide (TRAP; 600 M) or retro-sequence control peptide (600 M) on the
maintenance of contractile properties of wild-type DP cells transferred to a
medium containing 1% serum. **Significant difference from 1% FCS
(P<0.01).
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pathway (Phillips-Mason, 2000) but differentiation requires PKC
activation (Bogatkevich et al., 2001). Thus, in contrast to
differentiating fibroblasts, myofibroblastic transition in DP cells
does not require a distinct pathway and therefore seems to correlate
with reversion to a more proliferative state restricted in vivo to the
dermal sheath.
The simultaneous thrombin-induced loss of DP cell support of
the growth and survival of keratinocytes argues for a shift in
differentiation status rather than for a simple acquisition of new
contractile properties. In fact, thrombin signaling on DP cells leads
to cells expressing markers of both DP (alkaline phosphatase) and
DS (smooth muscle actin) cells, therefore resembling DSC cells.
Inductive properties (McElwee et al., 2003) and location of DSC
cells as well as our in vitro data suggest that those cells are
immediate precursors of DP cells. They may also be bipotent
progenitors of both DP and DS cells. Whether or not thrombin-
mediated stimulation of the PI3K-Akt pathway regulates
dedifferentiation in hair follicle dermal cells is clearly an important
question with both fundamental and practical implications.
The action of thrombin on DP cells requires the presence of its
receptor PAR-1, because it can be mimicked by addition of synthetic
thrombin-receptor-activating peptide. The absence of PAR-1 in DP
cells during anagen, seems to require epithelial-mesenchymal
interactions because isolated cells spontaneously re-express the
receptor in culture. The reverse of this, anagen-specific expression
of a versican-GFP transgene rapidly disappears in cultured DP cells
as it does in vivo during catagen (Kishimoto et al., 1999). Kishimoto
et al. previously proposed that the anagen-specific pattern of gene
expression in DP cells exhibits a spontaneous procatagen drift in
culture. However, our data show that in vitro drift actually correlates
with the acquisition of a DS-like phenotype by DP cells. This predicts
that genes active in both dermal cell types would not switch
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Fig. 5. Thrombin stimulates both growth and contractibility through activation of the PI3K/Akt pathway. (A) Percentages of wild-type and PN-1–/– (KO) cells
incorporating BrdU (10 M, 2 hours). The PI3K inhibitor LY294002 (LY; 50 M) and the mTOR inhibitor RAD001 (RAD; 20 nM) were added in 10% FCS
medium 24 hours before BrdU incorporation. ***Significant difference from wild-type cells (P<0.001). (B) Volume increase of cells switched to 1% FCS medium
and arrested with aphidicolin (1 g/ml, as in Fig. 3) determined after 24 hours with or without LY294002 or RAD001. *Significant difference from wild-type cells
(P<0.05). (C) Effects of LY294002 or GF103203X (5 M) on thrombin-stimulated (1 U/ml) collagen gel contraction by wild-type and PN-1–/– (KO) DP cells
pretreated with hirudin (100 M, 6 hours) and cultured in the presence of hirudin and aphidicolin. *Significant difference from wild-type cells (P<0.05).
(D) Relative levels of phospho-Akt and total Akt proteins in extracts from wild-type and PN-1–/– DP cells assessed by immunoblotting with the indicated
antibodies. Cells were either untreated (/) or cultured in the presence of LY294002 or RAD001 as in A. (E) Effect of thrombin on Akt phosphorylation examined by
adding thrombin (1 U/ml, 30 minutes) to wild-type DP cells grown in medium containing 1% FCS. The dependence of the thrombin effect on PI3K pathway was
assayed by adding LY294002 or RAD001 1 hour prior to thrombin. (F) Involvement of PAR-1 in Akt activation. Wild-type DP cells were treated with thrombin
(as in E), TRAP or control peptides (as in Fig. 4). (G) Comparison of the efficiency of thrombin stimulation of Akt phosphorylation in wild-type versus PN-1–/– DP
cells tested as in D. (H) Phosphorylation status of proteins of the PI3K pathway in lysates from dissected anagen whisker follicles of 20-day-old wild-type and
PN-1–/– littermates.
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expression in vitro. Although this hypothesis needs further
confirmation, it is worth noting that expression of PN-1 is indeed
maintained in isolated cultured DP cells.
The upregulation of PAR-1 and the downregulation of PN-1
during catagen seem to indicate a double security system to
optimally support the efficiency of thrombin signaling in this phase.
Furthermore, the differential expression of PAR-1 in DP and DS
during anagen and its upregulation in DP during catagen leads to
the intriguing question of whether PAR-1 expression in DS is needed
in vivo for the acquisition or maintenance of a non-DP phenotype.
It is likely that distinct regulation of PAR-1 expression in DP and
DS depends upon their different location and the different epithelial
cell types with which they interact. Interestingly, combining DS
cells with hair matrix cells can confer the capacity to act as DP-
like cells when grafted (Reynolds and Jahoda, 1996). Analysis of
how the cross-talk between matrix and papilla cells influences PAR-
1 expression, and thus the function of the thrombin regulatory
network, might improve our understanding of the regenerative
properties of hair follicles.
DP cells can be implanted in adult skin, where they induce the
formation of new hair follicles (Jahoda and Reynolds, 1996).
However, cultured DP cells progressively lose their inductive capacity
upon passages (Jahoda et al., 1984; Kishimoto et al., 1999). They
can, however, induce new follicles when implanted together with hair
matrix cells (Reynolds and Jahoda, 1996). Alternatively, the loss of
inductive capacity can be prevented by co-culture with Wnt3a-
producing feeder cells (Kishimoto et al., 2000). In this respect, our
data support a previous observation of Yu et al. (Yu et al., 1995),
who suggested a positive correlation between the relative level of
PN-1 expression in immortalized DP cell lines and their ability to
support hair growth in an in vivo follicular reconstitution assay. This
argues for a primordial role of thrombin-induced DP to DS-like shift
in loss of inductive capacity in vitro. Thus, our findings could be
relevant for skin and hair follicle reconstitution in providing new tools
for the in vitro engineering of hair follicle dermal cells. For example,
in vitro drift might be largely prevented or reverted upon exposure
to inhibitors of the thrombin-PAR-1-PI3K pathway.
Our results also stress the importance of the difference in control
of PAR-1 and PN-1 expression for regulating myofibroblastic
properties of dermal cells during the follicular cycle. In the DS, the
presence of PAR-1, thrombin and PN-1 during anagen suggests a
fine-tuning of DS cell properties sensitive to thrombin. Accordingly,
enhanced expression of SMA contractile protein and overactivation
of the PI3K-Akt pathway are observed in anagen hair follicles of
PN-1–/– mice. In the DP, by contrast, the downregulation of PAR-1,
the presence of PN-1 and the efficient elimination of PN-1-thrombin
complexes prevent thrombin signaling during anagen. This
observation could have a more general biological relevance. It was
shown that thrombin causes a marked delay in myogenesis (Guttridge
et al., 1997) and that PAR-1 signaling is repressed upon myocytes
fusion (Suidan et al., 1996). Using a myoblastic cell line, we found
that a drastic PAR-1 downregulation and strong PN-1 upregulation
are simultaneously detected upon myotube formation (supplementary
material Fig. S2). This could indicate a more general significance of
this double-lock principle. In hair follicles, the need for such a drastic
Fig. 6. Absence of PN-1 exacerbates the
detrimental effects of thrombin on the ability of
the DP cells to support keratinocytes.
(A,B) Effect of DP cells on the growth and
survival of keratinocytes. (A) Clusters formed
after 8 days by YF29 keratinocytes plated at
15,000 cells/cm2 on inactivated wild-type or
PN-1–/– DP feeder cells and visualized by
Rhodamine B staining. (B) Capacity of DP cells
to sustain cluster formation, quantified by
counting clusters of different size ranges.
***Significant difference from wild-type cells
(P<0.001). (C) Immunoblot evaluation of Akt
phosphorylation in keratinocyte to monitor the
signaling triggered by DP cells secreted
molecules. YF29 keratinocytes were maintained
in minimal medium (control) or transferred for
30 min to minimal medium conditioned for 24
hours by untreated DP cells (WT, KO for
PN-1–/–) or by cells pretreated with thrombin at
1 U/ml (WT+, KO+).
Fig. 7. In vivo wild-type dermal papilla expresses the DS marker SMA when
switched from anagen to catagen. (A) SMA expression in lysates of dissected
whisker follicles in anagen A and catagen C. (B) Immunostaining of cryostat
sections of wild-type back skin. SMA expression in the DS of hair follicles in
anagen (P12) and in the DS and DP in catagen (P15). (C) Co-expression of
SMA and AP in DP cells of wild-type back skin during catagen (P15). Left
image shows AP staining alone for comparison. SMA, alpha smooth muscle
cells actin; DS, dermal sheath; AP, alkaline phosphatase; DP, dermal papilla;
TS, trailer sheath.
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lock is clearly supported by our results suggesting that DP cells would
otherwise lose their ability to support keratinocytes. Lack of PN-1
in knockout mice is not sufficient to shift the DP cell phenotype during
anagen. However, in wild-type, the simultaneous disappearance of
PN-1 (Yu et al., 1995) and the re-expression of PAR-1 (Anan et al.,
2003) during catagen correlates with de novo expression of SMA.
Functionally, this enhancement of contractile properties by dermal
cells during regression of the follicle makes sense because it favors
maintenance of tight contacts between disorganized tissues and
possibly helps the upward movement of the follicle.
Change in size and cross-regeneration of dermal tissues involve
coordinated control of proliferation and migration of cells between
compartments (Jahoda, 1992; Tobin et al., 2003; McElwee et al.,
2003). Furthermore, renewal of dermal cells is coupled with hair
follicle cycling (Tobin et al., 2003). Since thrombin stimulates hair
follicle dermal cell proliferation in vitro, future studies may show
if in vivo cyclic up and down expression of thrombin regulators
helps such coupling. As thrombin activation of the PI3K-Akt
pathway simultaneously induce myofibroblastic conversion, cell
renewal may also rely on reversibility of differentiation status.
Materials and Methods
Animals
PN-1HAPN-1-lacZ/HAPN-1-lacZ (PN-1 KI) mice (Kvajo et al., 2004) and PN-1–/– mice (Luthi
et al., 1997) were each backcrossed for 12 generations into the C57BL/6 line (Arbresle,
France). All animal experiments were approved by the Swiss veterinary authorities.
X-gal staining, immunohistochemistry and immunocytochemistry
Vibrissal follicles were dissected out, fixed in Bouin’s solution or 4%
paraformaldehyde (PFA), and embedded in paraffin or in OCT (Sakura Finetek). For
-galactosidase histochemistry, longitudinal sections were stained according to
standard procedures (Sanes et al., 1986) and counterstained with Nuclear Fast Red
(Vector Laboratories).
Longitudinal sections (8-12 m thick) were incubated with various antibodies:
rabbit anti-thrombin (1/200, American Diagnostica), anti-human smooth muscle
actin/HRP (1/200, DakoCytomation), mouse anti-PN-1 [4B3, 1/200 (Mansuy et al.,
1993)] and stained with the Vectastain ABC peroxidase system (Vector Laboratories).
For immunocytochemical staining, cells were incubated with mouse anti-PN-1
(1/200), rabbit anti-LRP (1/200; a generous gift from D. K. Strickland, University
of Maryland School of Medicine, Baltimore, MD), mouse anti-BrdU (1/300; BD
Pharmingen), anti-alpha smooth muscle actin (1/200; Sigma-Aldrich) and anti-NCAM
NCL-L-CD56-1B6 (1/50; Novocastra) antibodies. Secondary antibodies Alexa Fluor
488 or 546 conjugated with either anti-mouse or anti-rabbit IgGs were used at 1/1000
for 2 hours at room temperature. Nuclei were visualized with DAPI.
Cell culture
Anagen vibrissal follicles from 3-month-old PN-1 wild-type (PN-1+/+) and PN-1–/–
mice were microdissected (Kobayashi et al., 1993) and the dermal papillas were
mechanically removed and dissociated in 1 trypsin-EDTA (Gibco-BRL). Rat DS
cells were obtained as described previously (Jahoda et al., 1991). Dissociated cells
were cultured in DMEM containing 10% FCS and 20 ng/ml human EGF (Upstate)
in a humidified atmosphere at 37°C under 10% CO2.
The mouse C2C12 myoblast cell line was obtained from ECACC (91031101).
Cells were cultivated at 37°C in DMEM containing 20% FCS, 2 mM L-glutamine
and penicillin-streptomycin (106 g/ml and 100 g/ml; Life Technologies Inc.). To
induce differentiation, myoblasts were allowed to grow to approximately 80%
confluency (usually 3 days after plating) and then switched to differentiation medium,
DMEM, supplemented with 2% horse serum (Finn et al., 2003). As soon as fusion
was apparent, 10 M AraC (Sigma) was added for 48 hours to eliminate the remaining
myoblasts.
Cell proliferation analysis
Wild-type and PN-1–/– DP cells were plated at 200 cells/mm2 and counted following
trypsinisation (mean of three different dishes) at different time points after splitting.
To measure BrdU incorporation 48 hours after plating, cells were treated with hirudin
(100 M; Calbiochem), PI3K inhibitor LY294002 (50 M; Cell Signaling) or mTOR
inhibitor RAD001 (20 nM; Novartis) 24 hours before addition of BrdU (10 M, for
2 hours; Sigma-Aldrich).
Cell volume analysis
DP cells were seeded to reach 80% confluency at the end of experiment. Cells were
transferred to 1% serum and 2 ng/ml EGF containing DMEM, arrested in S-phase
with 1 g/ml aphidicolin (Sigma-Aldrich) and further incubated for 24 hours. Increase
in cell size was measured by comparing cell volume at that time and after an additional
24 hours in culture in the presence or absence of recombinant PN-1 [15 nM (Sommer
et al., 1989)], recombinant human RAP (1.4 g/ml; Calbiochem), PI3K inhibitor
LY294002 (50 M) or mTOR inhibitor RAD001 (20 nM). The volumes and
distribution of viable resuspended cells were assessed in a Coulter Counter (Vi-CellTM
XR, Beckman-Coulter). Between 1000 and 3000 cells were counted per well and the
data analyzed using Coulter Multisizer Accucomp software (Beckman-Coulter).
Collagen gel contraction assay
The assay was adapted from Miki et al. (Miki et al., 2000). DP cells in suspension
(4 105 cells/ml) were mixed with collagen I (1.25 mg/ml, BD Biosciences), Hepes
(0.1 M; Fluka) and DMEM, transferred to a 24-well plate (300 l/well; Nunc) and
incubated at 37°C under 10% CO2 for 30 minutes. DMEM (500 l) containing 10%
FCS, 20 ng/ml EGF and 1 g/ml of aphidicolin was layered over the gel. Several
experiments were carried out in the presence of hirudin (100 M), LY294002 (50
M), GF109203X (5 M; Biomol), thrombin-receptor-activating peptide (TRAP;
600 M; SFLLRamide, Bachem) or retro-sequence peptide (600 M control, retro-
SLIGKVamide, Bachem). Contraction data are presented as the percentage reduction
in gel surface.
Keratinocyte survival assay
Human epidermal keratinocytes, strain YF29, were cultivated as previously described
by Rheinwald and Green (Rheinwald and Green, 1975). They were then seeded
(15,000 cells/cm2) on a feeder layer of mitomycin C (10 g/ml, for 2 hours; Sigma-
Aldrich)-treated wild-type, PN-1–/– DP cells or rat DP, DS cells and cultured in cFAD
keratinocyte medium (Gibco-BRL). On day 8, cells were fixed and stained with 1%
Rhodamine B (Fluka) as described previously (Brouard et al., 1999). Clusters from
eight or more keratinocytes were counted in the sampled central areas. Experiments
were done in triplicate.
To test DP cell signaling effects on the stimulation of the PI3K/Akt survival pathway
in keratinocytes, DP-conditioned medium (DPCM) was applied to YF29 cells for 30
minutes. DPCM was obtained by incubating serum-free keratinocytes medium
(SFKM; GIBCO BRL) for 24 hours with wild-type or PN-1–/– DP cells pretreated
or not with recombinant thrombin (1 U/ml; Sigma-Aldrich).
Proteolytic assays
Anagen vibrissal follicles were dissected out and homogenized. Total protein
concentration was determined (BioRad) and aliquots (10 g) of homogenates were
mixed with S-2238 (H-D-Phe-Pip-Arg-pNA·2HCl) substrate (1.25 mg/ml,
Chromogenix) and the amidolytic activity immediately determined as described
previously (Hengst et al., 2001).
Immunoblot analysis
SDS-PAGE and immunoblot analyses were used to identify phospho-PTEN(Ser380),
phospho-Akt(Ser473), phospho-S6 kinase 1(Thr389), phospho-FKHR(Ser256),
phospho-GSK3(Ser9), (all antibodies at 1/1000; Cell Signaling), HRP-SMA (1/8000;
DakoCytomation), PAR-1 (1/1000; Immunotech) and PN-1 (4B3 1/1000). Signals
were compared with those obtained with related antibodies (for p70-S6 kinase, and
Akt, 1/1000; Cell Signaling), and/or with anti-actin (1/3000; NeoMarkers).
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